Despite decades of efforts focused on mosquito eradication, drug therapies, and vaccines, malaria remains hard to beat, especially in Africa. The World Health Organization’s World Malaria Report 2024 ...

Scientists from Drexel University’s College of Medicine and Columbia University’s Irving Medical Center have uncovered a crucial structural feature of a key malaria drug target, known as PfATP4, and ...

Antibodies from malaria-exposed individuals have been found to target a diverse family of proteins from the malaria-causing parasite. These proteins cause severe disease by enabling infected blood ...

In a new study published in Nature, scientists have successfully developed genetically modified mosquitoes in Tanzania that block the transmission of malaria. The team includes researchers from the ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to a ...

WEHI researchers have visualized a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from spreading.

New discoveries about the malaria parasite made by researchers at Columbia and Drexel universities could change the way malaria is treated in the future. Subscribe to our newsletter for the latest sci ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Sam Darnold and Seahawks ...